Einzeltreffer — DigiBib

In this study, an efficient synthesis and the antimicrobial activity evaluation of some 4-oxo-thiazolidin-2-ylidene derivatives are presented. The structures of the target substances were confirmed by using 1 H and 13 C nuclear magnetic resonance spectroscopy, mass spectrometry, infrared spectroscopy, and elemental analysis. The synthesized compounds were evaluated for antimicrobial activity against five bacterial strains (Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus) and two fungal strains (Candida albicans and Cryptococcus neoformans). It was shown that the compounds in this series possess antibacterial and antifungal activities.

Titel:	Synthesis and biological evaluation of new 4-oxo-thiazolidin-2-ylidene derivatives as antimicrobial agents.
Autor/in / Beteiligte Person:	Chaban, T ; Matiichuk, Y ; Chulovska, Z ; Tymoshuk, O ; Chaban, I ; Matiychuk, V
Link:	Full Text Finder (Volltext)
Zeitschrift:	Archiv der Pharmazie, Jg. 354 (2021-07-01), Heft 7, S. e2100037
Veröffentlichung:	<2005->: Weinheim Germany : Wiley-VCH Verlag GmbH & Co. KGaA ; <i>Original Publication</i>: Weinheim, Verlag Chemie GmbH., 2021
Medientyp:	academicJournal
ISSN:	1521-4184 (electronic)
DOI:	10.1002/ardp.202100037
Schlagwort:	Anti-Bacterial Agents chemical synthesis Anti-Bacterial Agents chemistry Antifungal Agents chemical synthesis Antifungal Agents chemistry Bacteria drug effects Candida albicans drug effects Cryptococcus neoformans drug effects HEK293 Cells Humans Structure-Activity Relationship Thiazolidines chemical synthesis Thiazolidines chemistry Anti-Bacterial Agents pharmacology Antifungal Agents pharmacology Thiazolidines pharmacology
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article Language: English [Arch Pharm (Weinheim)] 2021 Jul; Vol. 354 (7), pp. e2100037. <i>Date of Electronic Publication: </i>2021 Apr 07. MeSH Terms: Anti-Bacterial Agents / pharmacology ; Antifungal Agents / pharmacology ; Thiazolidines / *pharmacology ; Anti-Bacterial Agents / chemical synthesis ; Anti-Bacterial Agents / chemistry ; Antifungal Agents / chemical synthesis ; Antifungal Agents / chemistry ; Bacteria / drug effects ; Candida albicans / drug effects ; Cryptococcus neoformans / drug effects ; HEK293 Cells ; Humans ; Structure-Activity Relationship ; Thiazolidines / chemical synthesis ; Thiazolidines / chemistry References: L. Piddock , Lancet Infect. Dis. 2012, 12, 249. https://doi.org/10.1016/S1473-3099(11)70316-4. ; G. Cheng , M. Dai , S. Ahmed , H. Hao , X. Wang , Z. Yuan , Front. Microbiol. 2016, 7, 470. https://doi.org/10.3389/fmicb.2016.00470. ; N. Kerru , L. Gummidi , S. Maddila , K. Gangu , S. Jonnalagadda , Molecules 2020, 25, 1909. https://doi.org/10.3390/molecules25081909. ; T. Tomasić , L. P. Masic , Curr. Med. Chem. 2009, 16, 1596. https://doi.org/10.2174/092986709788186200. ; D. Kaminskyy , A. Kryshchyshyn , R. Lesyk , Expert Opin. Drug Discov. 2017, 12, 1233. https://doi.org/10.1080/17460441.2017.1388370. ; D. Kaminskyy , A. Kryshchyshyn , R. Lesyk , Eur. J. Med. Chem. 2017, 140, 542. https://doi.org/10.1016/j.ejmech.2017.09.031. ; A. K. Jain , A. Vaidya , V. Ravichandran , S. K. Kashawa , R. K. Agrawal , Bioorg. Med. Chem. 2012, 20, 3378. https://doi.org/10.1016/j.bmc.2012.03.069. ; N. C. Desai , K. A. Jadeja , D. J. Jadeja , V. M. Khedkar , P. C. Jha , Synth. Commun. 2021, 51, 952. https://doi.org/10.1080/00397911.2020.1861302. ; R. Suryawanshi , S. Jadhav , N. Makwana , D. Desai , D. Chaturbhuj , A. Sonawani , S. Idicula-Thomas , V. Murugesan , S. Katti , S. Tripathi , R. Paranjape , S. Kulkarni , Bioorg. Chem. 2017, 71, 211. https://doi.org/10.1016/j.bioorg.2017.02.007. ; G. Bansal , P. Thanikachalam , R. Maurya , P. Chawla , S. Ramamurthy , J. Adv. Res. 2020, 23, 163. https://doi.org/10.1016/j.jare.2020.01.008. ; M. Ramirez , N. Borja-Hart , Pharmacotherapy 2008, 28, 646. https://doi.org/10.1592/phco.28.5.646. ; N. Agrawal , Curr. Chem. Lett. 2021, 10, 119. https://doi.org/10.5267/j.ccl.2020.11.002. ; D. R. Godhania , A. A. Jogela , P. B. Dobariyaa , A. M. Sanghanib , J. Saudi Chem. Soc. 2016, 20, S523. https://doi.org/10.1016/j.jscs.2013.03.002. ; R. F. George , Eur. J. Med. Chem. 2012, 47, 377. https://doi.org/10.1016/j.ejmech.2011.11.006. ; M. M. Ghorab , M. S. Al-Said , Y. M. Nissan , Arzneimittelforschung 2012, 62, 497. https://doi.org/10.1055/s-0032-1323660. ; M. M. Hanna , R. F. George , Chem. Pharm. Bull. 2012, 60, 1195. https://doi.org/10.1248/cpb.c12-00498. ; M. A. Salem , Croat. Chem. Acta 2017, 90, 7. https://doi.org/10.5562/cca295. ; T. Nasr , S. Bondock , S. Eid , J. Enzyme Inhib. Med. Chem. 2016, 31, 236. https://doi.org/10.3109/14756366.2015.1016514. ; S. A. Rostom , I. M. El-Ashmawy , H. A. Abd El Razikm , M. H. Badr , M. A. Hayam , Bioorg. Med. Chem. 2009, 17, 882. https://doi.org/10.1016/j.bmc.2008.11.035. ; M. H. M. Helal , M. A. Salem , M. S. A. El-Gabyd , M. Aljahdali , Eur. J. Med. Chem. 2013, 65, 517. https://doi.org/10.1016/j.ejmech.2013.04.005. ; T. Chaban , V. Horishny , M. Arshad , Z. Chulovska , L. Kostyshyn , I. Drapak , V. Matiychuk , Biointerface Res. Appl. Chem. 2021, 11, 12434. https://doi.org/10.33263/BRIAC114.1243412446. ; Z. Chulovska , I. Drapak , T. Chaban , V. Ogurtsov , V. Matiychuk , Eur. Chem. Bull. 2021, 10, 147. https://doi.org/10.17628/ecb.2021.10.147-154. ; N. T. Pokhodylo , Y. O. Teslenko , V. S. Matiychuk , M. D. Obushak , Synthesis 2009, 16, 2741. https://doi.org/10.1055/s-0029-1216875. ; T. I. Chaban , Y. E. Matiichuk , O.Y.a Shyyka , I. G. Chaban , V. V. Ogurtsov , I. A. Nektegayev , V. S. Matiychuk , Acta Chim. Slov. 2020, 67, 1035. https://doi.org/10.17344/acsi.2019.5439. ; N. T. Pokhodylo , V. S. Matiychuk , M. D. Obushak , Chem. Heterocycl. Compd. 2009, 45, 121. https://doi.org/10.1007/s10593-009-0238-2. ; Y. Bazel , A. Tupys , Y. Ostapiuk , O. Tymoshuk , V. Matiychuk , J. Mol. Liq. 2017, 242, 471. https://doi.org/10.1016/j.molliq.2017.07.047. ; T. I. Chaban , Y. E. Matiichuk , V. Y. Horishny , I. G. Chaban , V. S. Matiychuk , Russ. J. Org. Chem. 2020, 56, 813. https://doi.org/10.1134/S1070428020050139. ; N. T. Pokhodylo , V. S. Matiychuk , M. D. Obushak , Chem. Heterocycl. Compd. 2009, 45, 483. https://doi.org/10.1007/s10593-009-0287-6. ; A. Tupys , J. Kalembkiewicz , Y. Ostapiuk , V. Matiichuk , O. Tymoshuk , E., Woźnicka , Ł. Byczyński , J. Therm. Anal. Calorim. 2017, 127, 2233. https://doi.org/10.1007/s10973-016-5784-0. ; Z. Chulovska , T. Chaban , I. Drapak , V. Matiychuk , I. Chaban , I. Nektegaev , Biointerface Res. Appl. Chem. 2021, 11, 8009. https://doi.org/10.33263/BRIAC111.80098017. ; N. T. Pokhodylo , V. S. Matiychuk , J. Heterocycl. Chem. 2010, 47, 415. https://doi.org/10.1002/jhet.321. ; T. Chaban , V. Ogurtsov , A. Mahlovanyy , N. Sukhodolska , I. Chaban , S. Harkov , V. Matiychuk , Pharmacia 2019, 66, 171. https://doi.org/10.3897/pharmacia.66.e36764. ; N. T. Pokhodylo , V. S. Matiychuk , M. D. Obushak , Synthesis 2009, 8, 1297. https://doi.org/10.1055/s-0028-1087992. ; O. Tymoshuk , L. Oleksiv , L. Khvalbota , T. Chaban , I. Patsay , Acta Chim. Slov. 2019, 66, 62. https://doi.org/10.17344/acsi.2018.4570. ; T. Chaban , V. Ogurtsov , I. Chaban , I. Myrko , S. Harkov , M. Leluykh , Pharmacia 2019, 66, 27. https://doi.org/10.3897/pharmacia.66.e35131. ; N. Obushak , A. Lesyuk , Y. Gorak , V. Matiichuk , Russ. J. Org. Chem. 2009, 45, 1375. https://doi.org/10.1134/S1070428009090103. ; N. Obushak , Y. Gorak , V. Matiichuk , R. Lytvyn , Russ. J. Org. Chem. 2008, 44, 1689. https://doi.org/10.1134/S1070428008110213. ; WHO, Global Antimicrobial Resistance Surveillance System. Manual for Early Implementation 2015. https://www.who.int/antimicrobial-resistance/publications/surveillance-system-manual/en/ (accessed: December 2021). ; Open-access antimicrobial screening program. https://www.co-add.org (accessed: January 2021). Grant Information: project 2020.01/0166 National Research Foundation of Ukraine Contributed Indexing: Keywords: 4-oxo-thiazolidin-2-ylidenes; antimicrobial activity; synthesis Substance Nomenclature: 0 (Anti-Bacterial Agents) ; 0 (Antifungal Agents) ; 0 (Thiazolidines) Entry Date(s): Date Created: 20210407 Date Completed: 20211209 Latest Revision: 20211214 Update Code: 20231215

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Synthesis and biological evaluation of new 4-oxo-thiazolidin-2-ylidene derivatives as antimicrobial agents.